XML 36 R24.htm IDEA: XBRL DOCUMENT v3.24.3

Description Of Business Segments (Tables)

9 Months Ended

Sep. 30, 2024

Revenue from External Customer

Information Concerning Consolidated Operations by Business Segment

Information concerning consolidated operations by business segment is presented in the following tables:

						Three Months Ended September 30																		Nine Months Ended September 30
						2024						2023						Change						2024						2023						Change
NET SALES
Personal Care						$	2,635					$	2,700					-2		%				$	8,040					$	8,089					-1		%
Consumer Tissue						1,539						1,567						-2		%				4,624						4,750						-3		%
K-C Professional						767						854						-10		%				2,431						2,588						-6		%
Corporate & Other						11						11						N.M.						35						34						N.M.
TOTAL NET SALES						$	4,952					$	5,132					-4		%				$	15,130					$	15,461					-2		%
OPERATING PROFIT
Personal Care						$	482					$	502					-4		%				$	1,567					$	1,461					+7		%
Consumer Tissue						265						267						-1		%				800						707						+13		%
K-C Professional						161						168						-4		%				535						514						+4		%
Corporate & Other(a)						(318)						(128)						N.M.						(696)						(1,013)						N.M.
Other (income) and expense, net(a)						(564)						35						N.M.						(456)						(5)						N.M.
TOTAL OPERATING PROFIT						$	1,154					$	774					+49		%				$	2,662					$	1,674					+59		%

(a)    Corporate & Other and Other (income) and expense, net include income and expense not associated with the ongoing operations of the segments, including in 2024 the charges related to the 2024 Transformation Initiative, the impairment of intangible assets and the gain on sale of our PPE business. The 2024 Transformation Initiative charges related to the Personal Care, Consumer Tissue and K-C Professional business segments were $59, $37 and $21, respectively for the three months ended September 30, 2024 and $131, $65 and $46, respectively for the nine months ended September 30, 2024. In 2023, it includes the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets.

N.M. - Not Meaningful

^[1]

Sales of Principal Products

Sales of Principal Products:

						Three Months Ended September 30												Nine Months Ended September 30
						2024						2023						2024						2023
Baby and child care products						$	1,723					$	1,780					$	5,308					$	5,323
Consumer tissue products						1,539						1,567						4,624						4,750
Away-from-home professional products						767						854						2,431						2,588
All other						923						931						2,767						2,800
Consolidated						$	4,952					$	5,132					$	15,130					$	15,461

[1] Corporate & Other and Other (income) and expense, net include income and expense not associated with the ongoing operations of the segments, including in 2024 the charges related to the 2024 Transformation Initiative, the impairment of intangible assets and the gain on sale of our PPE business. The 2024 Transformation Initiative charges related to the Personal Care, Consumer Tissue and K-C Professional business segments were $59, $37 and $21, respectively for the three months ended September 30, 2024 and $131, $65 and $46, respectively for the nine months ended September 30, 2024. In 2023, it includes the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets.N.M. - Not Meaningful

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration